Vanta Bioscience Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1.48	2.22	1.61	0.97	2.24	26.5
Cash & Short-Term Investments	1.48	2.22	1.61	0.97	2.24	26.5
Cash Growth	-9.99%	37.93%	66.20%	-56.90%	-91.54%	1258.41%
Accounts Receivable	18.17	25.03	31.41	19.59	11.34	20.15
Other Receivables	-	40.63	41.29	-	37.21	35.27
Receivables	27.66	65.66	72.7	73.39	48.55	55.42
Inventory	77.31	65.07	75.21	71.58	72.36	97.64
Prepaid Expenses	-	0.5	0.46	-	1.27	2.35
Other Current Assets	5.06	20.12	21.64	6.5	20.57	17.45
Total Current Assets	111.51	153.57	171.61	152.43	144.98	199.36
Property, Plant & Equipment	102.83	239.62	284.06	332.29	373.15	348.59
Long-Term Investments	30	9.1	9.1	9.1	14.2	-
Other Intangible Assets	315.37	315.37	257.47	106.04	56.88	-
Long-Term Deferred Charges	-	134.66	125.34	239.95	215.86	138.66
Other Long-Term Assets	8.93	6.47	6.39	7.28	8.96	9.68
Total Assets	568.64	858.79	853.97	847.09	814.04	696.29
Accounts Payable	23.03	49.45	55.69	42.19	24.64	4.65
Accrued Expenses	-	45.6	39.74	26.5	32.89	33.69
Short-Term Debt	-	48.21	43.39	2.91	32.21	41.52
Current Portion of Long-Term Debt	75.64	111.38	77.22	98.04	46.49	39.81
Current Income Taxes Payable	-	-	-	-	0.39	0.62
Other Current Liabilities	40.46	11	11.82	7.83	6.17	28.14
Total Current Liabilities	139.13	265.64	227.86	177.47	142.79	148.43
Long-Term Debt	230.08	541.25	488.92	470.67	369.97	278.36
Long-Term Deferred Tax Liabilities	6.95	14.06	7.45	9.65	7.84	7.22
Other Long-Term Liabilities	-	-	-	-0	-	0
Total Liabilities	376.16	820.96	724.23	657.79	520.6	434.02
Common Stock	71.12	63.12	63.12	63.12	63.12	63.12
Additional Paid-In Capital	-	152.12	152.12	152.12	152.12	152.12
Retained Earnings	-	-111	-63.25	-40.09	24.83	23.95
Total Common Equity	192.49	104.24	151.99	175.15	240.07	239.19
Minority Interest	-	-66.41	-22.26	14.15	53.37	23.09
Shareholders' Equity	192.49	37.83	129.73	189.3	293.44	262.27
Total Liabilities & Equity	568.64	858.79	853.97	847.09	814.04	696.29
Total Debt	305.72	700.84	609.54	571.61	448.67	359.7
Net Cash (Debt)	-304.24	-698.62	-607.93	-570.65	-446.43	-333.2
Net Cash Per Share	-45.34	-110.68	-96.31	-90.41	-70.73	-52.79
Filing Date Shares Outstanding	7.11	6.31	6.31	6.31	6.06	6.31
Total Common Shares Outstanding	7.11	6.31	6.31	6.31	6.06	6.31
Working Capital	-27.62	-112.07	-56.25	-25.04	2.19	50.93
Book Value Per Share	27.09	16.51	24.08	27.75	39.63	37.89
Tangible Book Value	-122.89	-211.13	-105.48	69.11	183.19	239.19
Tangible Book Value Per Share	-17.30	-33.45	-16.71	10.95	30.24	37.89
Land	-	11.79	11.75	-	-	11.75
Buildings	-	99.67	99.67	-	-	60.02
Machinery	-	321.83	318.07	-	-	119.13
Construction In Progress	-	-	-	-	-	193.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.